D
Recursion Pharmaceuticals, Inc. RXRX
$4.94 $0.163.35% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -171.90M -202.49M -178.91M -95.84M -97.54M
Total Depreciation and Amortization 23.85M 19.33M 12.95M 7.20M 8.97M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 36.48M 57.05M 44.48M 26.75M 13.69M
Change in Net Operating Assets 35.15M -5.85M 6.05M 2.67M -7.33M
Cash from Operations -76.42M -131.96M -115.43M -59.23M -82.22M
Capital Expenditure -3.15M -1.83M -1.30M -4.56M -1.18M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- 277.10M -- --
Divestitures 0.00 -4.44M -- -- --
Other Investing Activities -2.66M -1.00M -350.00K 0.00 -3.00M
Cash from Investing -5.81M -7.27M 275.46M -4.56M -4.18M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -2.08M -2.05M -2.10M -2.29M -26.00K
Issuance of Common Stock 102.74M 42.57M 12.74M 18.75M 263.15M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -3.00M -- -- -- --
Cash from Financing 97.66M 40.53M 10.64M 16.46M 263.12M
Foreign Exchange rate Adjustments 9.26M 4.83M -3.47M 403.00K -118.00K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 24.69M -93.87M 167.19M -46.92M 176.60M